These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7030887)

  • 41. Fenofibrate and human liver. Lack of proliferation of peroxisomes.
    Gariot P; Barrat E; Mejean L; Pointel JP; Drouin P; Debry G
    Arch Toxicol; 1983 Jun; 53(2):151-63. PubMed ID: 6882216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of clofibric and beclobric acid in rat and monkey hepatocyte primary culture: influence on peroxisomal and mitochondrial beta-oxidation and the activity of catalase, glutathione S-transferase and glutathione peroxidase.
    Mennes WC; Wortelboer HM; Hassing GA; van Sandwijk K; Timmerman A; Schmid BP; Jahn U; Blaauboer BJ
    Arch Toxicol; 1994; 68(8):506-11. PubMed ID: 7802591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship.
    Sharma R; Lake BG; Foster J; Gibson GG
    Biochem Pharmacol; 1988 Apr; 37(7):1193-201. PubMed ID: 3355593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the short-term hepatic effects of orally administered citral in Long Evans hooded and Wistar albino rats.
    Jackson GM; Hall DE; Walker R
    Food Chem Toxicol; 1987 Jul; 25(7):505-13. PubMed ID: 3623339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microsomal and cytosolic epoxide hydrolases, the peroxisomal fatty acid beta-oxidation system and catalase. Activities, distribution and induction in rat liver parenchymal and non-parenchymal cells.
    Steinberg P; Schladt L; Dienes HP; Timms C; Oesch F
    Eur J Biochem; 1988 Sep; 176(1):39-45. PubMed ID: 3416872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzymatic changes in rat liver associated with low and high doses of a peroxisome proliferator.
    Berge RK; Hosøy LH; Aarsland A; Bakke OM; Farstad M
    Toxicol Appl Pharmacol; 1984 Mar; 73(1):35-41. PubMed ID: 6143426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
    Chevalier S; Roberts RA
    Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of some hypolipidemic drugs on biochemical values and on hepatic peroxisomal enzymes of normolipemic rat.
    Watanabe T; Manna H; Suga T
    J Pharmacobiodyn; 1981 Oct; 4(10):743-50. PubMed ID: 6798192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peroxisome proliferation and microsomal enzyme induction by the hypolipidemic CI-924 in rats and mice: relationship to tumorgenicity.
    Hofstra AH; King LM; Walker RM
    Fundam Appl Toxicol; 1995 Sep; 27(2):277-86. PubMed ID: 8529824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species.
    Eacho PI; Foxworthy PS; Johnson WD; Hoover DM; White SL
    Toxicol Appl Pharmacol; 1986 May; 83(3):430-7. PubMed ID: 3754661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic induction potency of hypolipidaemic drugs in the rat following long-term administration: influence of different dosing regimens.
    Makowska JM; Bonner FW; Gibson GG
    Xenobiotica; 1990 Nov; 20(11):1121-8. PubMed ID: 2275209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
    Berman JS; Hiley CR; Wilson AC
    Br J Pharmacol; 1983 Mar; 78(3):533-41. PubMed ID: 6839062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate.
    Leung LK; Glauert HP
    Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.
    Svoboda D; Azarnoff D; Reddy J
    J Cell Biol; 1969 Mar; 40(3):734-46. PubMed ID: 5765763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypolipidemic effect and enhancement of peroxisomal beta-oxidation in the liver of rats by sodium-(E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl propenoate (OKY-1581), a potent inhibitor of TxA2 synthetase.
    Watanabe T; Utsugi M; Mitsukawa M; Suga T; Fujitani H
    J Pharmacobiodyn; 1986 Dec; 9(12):1023-31. PubMed ID: 3572715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peroxisome proliferator-activated receptors: finding the orphan a home.
    Green S; Wahli W
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequential histologic study of rat liver during peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]-acetic acid (Wy-14,643)-induced carcinogenesis.
    Rao MS; Lalwani ND; Reddy JK
    J Natl Cancer Inst; 1984 Oct; 73(4):983-90. PubMed ID: 6592391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.
    Baumgart E; Völkl A; Pill J; Fahimi HD
    FEBS Lett; 1990 May; 264(1):5-9. PubMed ID: 2338145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
    Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
    Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabeling.
    Randerath E; Randerath K; Reddy R; Danna TF; Rao MS; Reddy JK
    Mutat Res; 1991 Mar; 247(1):65-76. PubMed ID: 2002806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.